Back to GEN Stock Lookup

GEN – Company Press Releases

Apr 17, 2014 05:24 PM GSK and Genmab receive FDA approval for Arzerra® (ofatumumab) as first-line treatment in combination with chlorambucil for patients with Chronic Lymphocytic Leukaemia (CLL) for whom fludarabine-based
Apr 17, 2014 03:52 PM GSK and Genmab Receive FDA Approval for Arzerra(r) (ofatumumab) as First-Line Treatment in Combination with Chlorambucil for Patients with Chronic Lymphocytic Leukemia (CLL) for Whom Fludarabine-Based
Apr 9, 2014 11:11 AM Passing of Genmab A/S' Annual General Meeting
Mar 26, 2014 06:57 PM Genmab Reaches $22 Million Milestone in Daratumumab Collaboration with Janssen
Mar 5, 2014 12:47 AM Genmab Announces Phase III Study of Daratumumab in Relapsed or Refractory Multiple Myeloma
Mar 4, 2014 06:47 PM GeneNews Reports Full Year and Q4 2013 Financial Results
Mar 4, 2014 11:23 AM Genmab 2013 Annual Report
Feb 5, 2014 07:15 AM Arzerra(R) Fourth Quarter and Full Year 2013 Net Sales Figures
Jan 29, 2014 01:57 PM Major Shareholder Announcement
Jan 21, 2014 08:30 AM GeneNews' Innovative Diagnostic Laboratory J-V Initiates U.S.-Wide Roll Out of ColonSentry(R) and Adds Important New Test to Offering Menu

Back to GEN Stock Lookup